Return to search results
Zonisamide
Zonisamide is a generic anti-epileptic drug used to control seizures by reducing abnormal electrical activity in the brain. It belongs to the sulfonamide class and acts as a carbonic anhydrase inhibitor. Available as oral capsules in 25mg, 50mg, and 100mg strengths, manufactured by Sun Pharmaceutical Industries, Inc. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Zonisamide is a generic anti-epileptic drug used to control seizures by reducing abnormal electrical activity in the brain. It belongs to the sulfonamide class and acts as a carbonic anhydrase inhibitor. Available as oral capsules in 25mg, 50mg, and 100mg strengths, manufactured by Sun Pharmaceutical Industries, Inc. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Zonisamide",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Zonisamide — ANDA 077625 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=077625"
}
]
|
| identifier | ANDA077625 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"health-care",
"medications",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Zonisamide |
